ARKG

ARK Genomic Revolution Multi-Sector ETF
CLOSING PRICECHANGE (%)VOLUME
$22.50+0.12 (0.56%)9.06K
3:04:00 p.m. (ET) 07/21/2017
BZX EXCHANGE CLOSED
LAST TRADECHANGE (%)
---- (--)
BID SIZEBID ($)ASK ($)ASK SIZE
--------
C

37
  • Overview
  • Efficiency
  • Tradability
  • Fit

ARKG Fund Description

The ARK Genomic Revolution Multi-Sector ETF is an actively managed fund that targets companies involved in the genomics revolution.

ARKG FactSet Analytics Insight

ARKG is not your typical health care or biotech sector fund. It reaches across multiple sectors for companies that the advisor believes will benefit from innovations in the genomics-related industry. As such, the fund covers 5 sectors, with the majority of its weighting in health care companies. It charges a high fee for its actively managed thematic strategy. Investors considering ARKG need to be comfortable with its niche strategy and its management team. Trade the fund with care.

ARKG MSCI ESG Fund metrics Insight

The MSCI ESG Fund Quality Score measures the ability of ETF underlying holdings to manage key medium to long-term risks and opportunities arising from environmental, social, and governance factors, as determined by MSCI ESG Research LLC. As of July 20, 2017 the ARK Genomic Revolution Multi-Sector ETF MSCI ESG Fund Quality Score is 4.49 out of 10.

The fund’s Peer Rank reflects the ranking of a fund’s MSCI ESG Fund Quality Score against the scores of other funds within the same peer group, as defined by the Thomson Reuters Lipper Global Classification. ARKG ranks in the 0th percentile within its peer group and in the 20th percentile within the global universe of all funds in MSCI ESG Fund Metrics coverage.

  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max
COMPARE
RESET
Select ETFs to compare their performance:

ARKG Top 10 Countries View All

ARKG Top 10 Sectors

ARKG Top 10 Holdings View All

ARKG Summary Data

10/31/14
Open-Ended Fund
0.75%
$23.41 M
$423.13 K
0.28%

ARKG Portfolio Data

$19.16 B
-11.05
5.49
0%
N/A
36

ARKG Index Data

No Underlying Index
Proprietary
Proprietary
Thomson Reuters Global Biotechnology & Medical Research

Related ETFs to ARKG

BBH
Total Return
  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max

ARKG Portfolio Management

0.75%
--
--
--

ARKG Tax Exposures

20.00% / 39.60%
--
Qualified dividends
No

ARKG Fund Structure

Open-Ended Fund
No
No
0% / 100%
N/A
N/A
High
Daily
Bats Book Viewer
TOP OF BOOK
SHARES/SIZEPRICE
ASKS----
----
----
----
----
BIDS----
----
----
----
----
LAST 10 TRADES
TIMEPRICESHARES
12:32:3222.59100
10:59:2922.5021
------
------
------
------
------
------
------
------
Bats BZX Real-time Quote - 23:59:59
Daily Spread
Premium/Discount
Volume

ARKG FactSet Analytics Block Liquidity

As of 07/21/17
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of ARKG. ARKG is rated a 2 out of 5.

ARKG Tradability

19,184
$423.13 K
13,831
$297.48 K
0.28%
$0.06
0.06%
1.28% / -1.71%
None
100.00%
50,000
0.28
0.05%
1.21%
--
$22.38
2

ARKG Performance Statistics

0.69
1.26
1.08
1.45
0.97%
Thomson Reuters Global Biotechnology & Medical Research

ARKG MSCI ESG Fund Metrics

4.49 / 10
--
19.86
1.32%
5.91%
24.01